NYU Langone, Long Island — Mineola, New York

NYU Langone, Long Island is a clinical research site located in Mineola, New York, United States 11501.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

NYU Langone, Long Island has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer.

Sponsors: Imunon.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU Langone, Long Island?

NYU Langone, Long Island has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU Langone, Long Island conducted?

NYU Langone, Long Island has 1 clinical trials on record, with 1 currently active. Their work covers Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer.

Is NYU Langone, Long Island accredited by Crixeo Health?

NYU Langone, Long Island has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NYU Langone, Long Island?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.